US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist
  • 48.5500
  • +3.5500+7.89%
Close May 20 16:00 ET
518.84MMarket Cap-7036P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.83

+80.42%
Analyst Rating

Strong Buy

May 13, 2024

Corbus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 100.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 100.000K--

Unlock Free Earnings Estimates

Corbus Pharmaceuticals Earnings Reports

  • Corbus Pharmaceuticals | 10-Q: Quarterly report

    May 8 04:40

  • Corbus Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 21 05:13

  • Corbus Pharmaceuticals | 10-K: Annual report

    Mar 13 05:24

  • Corbus Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 05:57

    • Read more

    Analysis

    Analyst Rating

    Updated: May 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg